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maintenance of E-cadherin at adherens junctions
Takashi Ohama1,2†, Lifu Wang1†, Erin M Griner1 and David L Brautigan1*Abstract
Background: Epithelial tissues depend on intercellular homodimerization of E-cadherin and loss of E-cadherin is
central to the epithelial to mesenchymal transition seen in multiple human diseases. Signaling pathways regulate
E-cadherin function and cellular distribution via phosphorylation of the cytoplasmic region by kinases such as
casein kinases but the protein phosphatases involved have not been identified.
Results: This study shows protein Ser/Thr phosphatase-6 catalytic subunit (PP6c) is expressed in epithelial tissue
and its mRNA and protein are robustly up-regulated in epithelial cell lines at high vs. low density. PP6c accumulates
at adherens junctions, not tight junctions, co-immunoprecipitates with E-cadherin-catenin complexes without a
canonical SAPS subunit, and associates directly with the E-cadherin cytoplasmic tail. Inducible shRNA knockdown of
PP6c dispersed E-cadherin from the cell surface and this response was reversed by chemical inhibition of casein
kinase-1 and prevented by alanine substitution of Ser846 in murine E-cadherin.
Conclusions: PP6c associates with E-cadherin in adherens junctions and is required to oppose casein kinase-1 to
maintain cell surface localization of E-cadherin. There is feedback signaling to enhance PP6c transcription and boost
protein levels in high density epithelial cells.
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The physiological function and physical integrity of epi-
thelial tissues depends on contacts between cells that
include adherens junctions and tight junctions (for
review [1]). Adherens junctions are cell-cell attachments
of epithelial cells that are required for the subsequent
construction of tight junctions and maintenance of
cell polarization. Adherens junctions are based on
Ca2+-dependent homotypic interactions of the extracellu-
lar domains of E-cadherin between neighboring cells.
The cytosolic portion of the transmembrane E-cadherin
is best known to bind to β-catenin, but as many as 170
proteins are reported to colocalize and/or associate with
cadherin in adherens junctions in what has been called
the “Cadhesome” [2].* Correspondence: db8g@virginia.edu
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reproduction in any medium, provided the orE-cadherin mediated cell-cell junctions play an import-
ant role in contact inhibition of cell growth, and loss of
E-cadherin expression occurs during tumor progression
and metastasis [3,4]. This makes it important to under-
stand the mechanisms that govern E-cadherin expres-
sion and distribution to the cell surface. Wnt signaling
plays a role in the distinctive switching of gene ex-
pression in epithelial cells. Wnt activity is dramatically
decreased after formation of cell-cell contacts [5]. The
E-cadherin/catenin complex physically associates with
the Wnt co-receptor and is necessary for downstream
β-catenin activation [6,7].
Phosphorylation is an established mechanism for regulat-
ing cadherin, and E-cadherin/catenin complexes are regu-
lated by Ser phosphorylation [8]. Casein kinase 2 (CK2)
and glycogen synthase kinase 3β (GSK3β) phosphorylate
human E-cadherin at Ser838, Ser853, and Ser855, which
enhances the interaction with β-catenin [9]. On the other
hand, CK1 phosphorylation of human Ser844 (mouse
Ser846) in the same region of E-cadherin disrupts cell-cell
contacts with internalization of E-cadherin [10]. These
phosphoSer sites in E-cadherin constitute a recognition siteLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Immunohistochemistry for PP6 in normal human
colon. Sections were stained with hematoxylin and eosin (A) and
immunostained with anti-PP6 using peroxidase to give brown color (B).
The droplets of mucosal fluid in goblet cells appear blue in (A) and
white in (B) and these structures are surrounded by the continuous
layer of epithelial cells with high levels of PP6. The scale bar represents
10 um. Multiple sections from two independent specimens were
stained and examined.
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E-cadherin, with an increase in cell migration and
tumorigenesis [11]. The protein Ser/Thr phosphatases that
regulate E-cadherin by countering CK1 and CK2 phos-
phorylation are unknown.
Here, we discovered protein phosphatase-6 (PP6), which
is highly expressed in epithelial cells, localizes to adherens
junctions and associates with E-cadherin/catenin com-
plexes in human epithelial cells. Levels of PP6c mRNA and
protein are significantly increased in confluent cells and in-
ducible RNAi to deplete PP6c in confluent monolayers re-
sults in internalization of E-cadherin. The effects of PP6c
knockdown are prevented by chemical inhibition of CK1
or by mutation of Ser846 in mouse E-cadherin to a non-
phosphorylated Ala, showing PP6c requires this site in
E-cadherin to regulate localization in adherens junctions.
Our results show PP6 is a key regulator of E-cadherin
and suggests feedback up-regulation of PP6 to support
E-cadherin localization.
Results
Protein phosphatase-6 in human epithelial cells
Protein phosphatase-6 catalytic subunit (PP6c) ex-
pression is highest in the gastrointestinal tract and in
hematopoietic cells, based on tissue analyses of mRNA and
protein in GeneAtlas (biogps.org) and ProteinAtlas
(proteinatlas.org). We stained sections of normal human
colon with hematoxylin and eosin (H&E, Figure 1A) and
for PP6c by immunohistochemistry (Figure 1B). There was
intense PP6c staining in the epithelial cells, seen as a con-
tinuous layer of cells surrounding the large unstained gran-
ules of mucosal fluid (that are blue by H&E). Staining for
PP6c in the surrounding mesenchymal cells (red by H&E)
was much weaker. A few scattered cells that stained in-
tensely for PP6c we suspect were infiltrating lymphocytes.
To study PP6 in human epithelial cells we chose Caco-2
cells, which have been well characterized over the years as
a model for the intestinal epithelium [12].
Caco-2 cells were seeded so as to reach confluence
within days of culture and cells were fixed and stained
for PP6c at various times. Laser-scanning confocal mi-
croscopy showed immunofluorescent localization of the
endogenous PP6c initially in the perinuclear region, and
subsequently as predominantly cytosolic, with little or
no staining in the nuclei (Figure 2B, C). These obser-
vations are consistent with previous reports of PP6c
being predominantly cytosolic [13,14]. The first days
after replating PP6c immunostaining of individual cells
appeared at either high or low intensities. Areas with
higher density cells, where nuclei were closer together
(e.g. top third of Figure 2B) showed higher intensity
PP6c compared to areas with lower density cells (lower half
of Figure 2B). When cultures became confluent (Figure 2C)
the PP6c was distributed uniformly throughout the cells,and we noted the staining intensity was higher than on
previous days.
The increase in PP6c was confirmed by quantitative
immunoblotting of cells harvested at various times after
re-plating (Figure 2D). The results demonstrated that
relative levels of PP6c protein dramatically increased
(~8-fold) between 3 and 7 days, when cells reached 100%
confluence, and these higher levels more than doubled
again over the next two weeks (days 14–28). By compari-
son levels of the PP6-specific regulatory subunits PP6R1
and PP6R3, the dominant endogenous partners for PP6c,
did not increase over the first two weeks and showed
only slightly increased levels after 3 to 4 weeks of
culture (Figure 2D), indicating their expression was not
co-dependent with PP6c. There was a step-wise increase
in the amount of PP6R2 (two bands that are presumably
different spliced forms, commonly seen) at 7 days after
the cells had reached confluence and this level persisted
Figure 2 Accumulation of PP6 protein in high density epithelial
cells. (A-C) Caco-2 cells were cultured on Nunc Lab-Tek II Chamber
slide 4 well (72,000 cells/ well) and cultured for 1 (A), 3 (B) and 7 (C)
days. Cells were fixed, permeabilized and stained with anti-PP6
antibodies and images captured with an Olympus confocal microscope.
Similar results were obtained in 3 independent experiments. (D) Caco-2
cells were cultured for indicated time periods and extracts analyzed for
the indicated proteins by immunoblotting. Numbers below frame are
the relative fluorescent intensity of PP6c staining determined with an
Odyssey 2D scanner (Licor Industries). Images are representative of two
independent experiments. (E) Different numbers of human ARPE19
epithelial cells were seeded and after 4 days confluency estimated from
microscopic examination (as indicated). Levels of PP6 protein were
determined by immunoblotting, with actin as a loading control for total
protein. Images are representative of two independent experiments.
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pression was different from any of its regulatory sub-
units. Actin was used as a loading control to insure the
same amount of total cell protein was analyzed on theimmunoblots (Figure 2D, bottom panel). These observa-
tions support the hypothesis that the PP6c was accumu-
lating in cells without a corresponding increase in one
of its canonical SAPS partners.
The multi-fold increase in PP6c protein levels was un-
expected and unusual for a Ser/Thr phosphatase. By
comparison, there was no detectable change over the
entire time course, up to 28 days, in the levels of the
closely related phosphatase PP2A catalytic subunit (PP2Ac)
or its specific scaffolding subunit (PP2A-A) (Figure 2D).
This shows the cell density changes in expression levels
were not common among PPP phosphatases. Previous
studies have shown that PP2A is under stringent feedback
control, keeping the protein levels within a relatively nar-
row range [15,16]. Levels of α4, the atypical subunit that
binds to all type 2A phosphatases (PP2A, PP4 and PP6)
also did not change when Caco-2 cells formed confluent
monolayers. Because neither α4 nor PP2A levels changed
we concluded it was unlikely that α4 was involved in the
increase in PP6.
We also examined cell-density dependent increase of
PP6c expression in human ARPE-19 pigmented retinal
epithelial cells. Different number of cells (2.5, 5, 10 and
15 × 104 cells) were seeded in 6 well plates and cultured
for 4 days at which time they were at 40-50%, 80-90%,
90-100% confluent and 100% post-confluent, respect-
ively. The PP6c content of ARPE-19 cells increased with
cell density and was much higher in near-confluent and
post-confluent cells (Figure 2E). These results showed
different human epithelial cell lines exhibit cell density-
dependent increase in expression of the catalytic subunit
of PP6.
Enhanced PP6c expression in high-density epithelial cells
We examined what might contribute to the elevated
PP6c protein levels in high density cells. The increase
was due at least in part to elevation of the steady-state
levels of PP6c mRNA. We used quantitative real-time
PCR to compare PP6c mRNA in Caco-2 cells plated at
different densities and found that high density cells had
significantly (p<0.05) more PP6c mRNA compared to
low density cells (Figure 3A). Levels of PP6c also can be
controlled by at least two miRNA, miR31 and miR373, and
changes in these miRNA and the levels of PP6c have been
linked to different types of cancer [17,18]. Our assays
showed there was a significant increase in both miR31 and
miR373 in high density vs. low density cells (Figure 3B, C).
These results run counter to expectations, because an in-
crease in levels of miRNA targeting PP6c would be pre-
dicted to reduce, not increase, protein production. We
concluded that miR31 and miR373 are not the dominant
factors controlling PP6c levels in Caco-2 cells.
The increase in PP6c mRNA levels in high density
cells corresponded to increased transcription of the PP6c
Figure 3 Regulation of PP6 expression in Caco-2 cells. (A) Caco-2 cells were seeded at < 30% and > 90% confluency as low and high density
cultures. After 4 days levels of PP6 mRNA were assayed by quantitative RT-PCR and the average and standard deviation were plotted (n=3). There
was a statistically significant increase in PP6 mRNA relative to GAPDH, used as endogenous control. Quantitative PCR was used to assay the levels
of miR31 (B) and miR373 (C) in low and high density Caco-2 cells. Experiments were replicated (n=3) and the mean and standard deviation
plotted and analyzed for statistical significance. (D) The ratio of firefly to Renilla luciferase activities in Caco-2 cells co-transfected with a PP6c
promoter-reporter and a control plasmid. The ratio was normalized to low density cells in three independent experiments done in triplicate,
showing a highly significant increase in PP6 promoter activity in high density cells. (E) Immunoblotting for endogenous PP6c, cyclin D1 and
PP2Ac in high density Caco-2 cells treated for the indicated periods of time with 100 μg/ml cycloheximide.
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transcriptional start site and used this as a proximal pro-
moter for expression of firefly luciferase. A dual luciferase
system was used to assay for activity of the PP6 promoter.
Activity of firefly luciferase was normalized to Renilla lucif-
erase expressed from a separate plasmid that was co-
transfected into cells. Transcription driven by the PP6c
promoter was nearly doubled in cells plated at high
density vs. low density, a statistically significant difference
(p<0.001; Figure 3D). The relative increase in transcription
corresponded to the increase in the mRNA levels we ob-
served, but do not seem to adequately account for the 15
to 20-fold increase in protein levels.
To test for a change in protein degradation we added
cycloheximide to inhibit translation in high density
Caco-2 cells and observed that levels of both PP6c and
PP2Ac proteins were only slightly reduced after 1, 2, or
3 days (Figure 3E). In contrast, as a positive control, the
levels of cyclin D1 in these cells were fully depleted
within the first 24 hr (Figure 3E). Thus, there seemed to
be a limited amount of PP6c degradation in high density
cells. The low levels of PP6c protein made it difficult to
observe degradation in low density cells. We concluded
that an increase in transcription, elevated levels of
mRNA, and a low rate of protein degradation probablyaccounted for the accumulation of PP6c protein in high
density epithelial cells.
Association of PP6c with E-cadherin
In high density Caco-2 cells we observed concentra-
tion of endogenous PP6c along the cell-cell boundaries
by immunofluorescent confocal scanning microscopy
(Figure 4A, B, green). We used double immunostaining
to examine whether PP6 was localized to adherens junc-
tions or tight junctions in different optical sections. PP6
co-localized (yellow in merged image) in the same Z plane
section with E-cadherin (red), a marker of adherens junc-
tions (Figure 4A). On the other hand, PP6 did not overlap
or co-localize with occludin (red), a tight junction protein
(Figure 4B). The results revealed specific localization of
PP6 at adherens junctions.
The localization of PP6c at adherens junctions promp-
ted us to test for association of PP6c with E-cadherin
by co-immunoprecipitation of the endogenous pro-
teins in Caco-2 cells. First, we separated cytosolic and
membrane fractions by sucrose gradient centrifugation
and analyzed protein distribution by immunoblotting
(Figure 4C). Effective separation of membranes from
cytosol was demonstrated by GAPDH as a cytosolic
marker and beta-integrin as a membrane marker. The
Figure 4 Association of PP6 with Adherens Junction complexes. Caco-2 cells were immunostained for (A) PP6 (green) and E-cadherin (red),
with yellow showing extensive overlap and (B) PP6 (green) and occludin (red) with essentially no co-localization. Confocal microscope images are
selected from 3 independent experiments that had the same results. (C) Cytosolic and membrane fractions of Caco-2 cells were separated by
sucrose gradient, and indicated proteins detected by immunoblotting samples of 10 or 20 μg total protein. Images are representative of two
independent experiments. (D) Endogenous PP6c was immunoprecipitated from cytosolic and membrane fractions of Caco-2 cells in parallel with
samples using non-immune rabbit IgG as control. Immuncomplexes were resolved by SDS-PAGE and immunoblotted for PP6c, E-cadherin, and α
and β cateninin. Images are representative of two independent experiments. (E) E-cadherin was immunoprecipitated from the membrane
fraction, and normal rabbit IgG used as control and samples immunoblotted for recovery of E-cadherin, PP6c, PP6R1, PP6R2 and PP6R3. Images
are representative of two independent experiments. (F) S-tagged PP6c and empty vector control (Cont.) were used in pull-down assay with 35S
radiolabeled cytosolic domain of E-cadherin expressed in a cell free system, as described. The bound and unbound proteins were resolved by
SDS-PAGE and the gel used for exposure of a PhosphorImager plate to compare the amounts of bound E-cadherin domain. Images are
representative of two independent experiments.
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covered in the membrane fraction, as expected. Conversely,
phosphatases PP6c and PP2Ac were predominantly in
the cytosol, with limited amounts recovered in the
membrane fraction (Figure 4C). Immunoprecipitation
with anti-PP6c antibody compared to a non-specific
IgG as negative control demonstrated selective recovery
of PP6c from either the cytosol or membrane fractions
(Figure 4D, lanes 2 and 4, bottom panel). From the mem-
brane fraction, but not from the cytosol, there was spe-
cific co-precipitation of PP6c with E-cadherin, as well as
α-catenin and β-catenin (Figure 4D). Furthermore, in a
reciprocal immunoprecipitation, anti-E-cadherin anti-
body co-precipitated PP6c from the membrane fraction,
compared to non-specific IgG as a negative control to
show specificity (Figure 4E). None of the canonical PP6
subunits PP6R1, R2 or R3 were detected in the immuno-
precipitates (Figure 4E). We concluded that endogenousPP6 forms stable complexes with E-cadherin/catenin in
the adherens junctions of Caco-2 epithelial cells. The
regulatory subunits of PP6 were not detected by im-
munoblotting in the E-cadherin complexes prepared by
immunoprecipitation from membranes. This supported
the idea that PP6c associated with E-cadherin without
participation of the SAPS subunits.
To test for direct protein-protein interaction between
PP6c and E-cadherin, we used a pull-down assay with
purified S-tagged PP6c on beads mixed with the cytosolic
domain of E-cadherin (Figure 2F). The S-tag PP6c was
expressed in 293T cells, and recovered on S-protein beads
that were washed with 2 M urea, which was sufficient to
leave only the S-tag PP6c on the beads, based on silver
staining after SDS-PAGE (not shown). The E-cadherin
cytosolic domain was detected as a single 35S-radiolabeled
protein produced by in vitro transcription and transla-
tion. Using essentially identical amounts of 35S-E-cadherin
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specific binding to control S-protein beads, but consider-
ably more binding with S-tag PP6c on the beads (Figure 4F).
The results provide evidence for a direct protein-protein
interaction between PP6c and the cytoplasmic tail of
E-cadherin.
PP6 is required for maintenance of E-cadherin
at adherens junctions
Testing whether PP6 affects E-cadherin function or local-
ization at adherens junctions poses experimental chal-
lenges. There are no pharmacological inhibitors specific for
PP6 relative to other PPP phosphatases, and we found
knockdown of PP6c in epithelial cells by siRNA transfec-
tion prevented formation of confluent monolayers. As an
alternative approach we generated lentiviruses using
TRIPZ vectors, with doxycycline (dox) inducible expres-
sion of shRNA targeting PP6c. Inducible knockdown of
PP6c in confluent Caco-2 cells disrupted E-cadherin and
β-catenin localization at adherens junctions, but did not
alter localization of either tight junction protein occludin
or ZO-1 (Figure 5A), demonstrating that the actions
of PP6c are highly localized and specific. The endogenousFigure 5 Localization of endogenous E-cadherin in response to PP6c
down of PP6c Caco-2 cells were infected with a lentivirus (A) or an adenov
control. After 4 days the cells were immunostained for indicated proteins and
10 μM IC261 for 4 hr. Immunofluorescent images of E-cadherin in control and
fluorescence intensity of E-Cadherin in (B) by line scans (10 μm). (D) The full w
according to description in Methods, and average values of 20 such scans [26
PP6c, PP2Ac, E-cadherin and actin in cells with PP6c knockdown compared toE-cadherin was removed from the cell-cell junctions into a
juxtamembrane region and also was dispersed throughout
the cytosol. Treatment of the cells with casein kinase-1
(CK1) inhibitor IC-261 prevented this relocalization of
E-cadherin in response to knockdown of PP6c (Figure 5B).
The rescue of the PP6c knock down phenotype by inhib-
ition of CK1 is consistent with the idea that these enzymes
were opposing one another.
To analyze the redistribution of E-cadherin we per-
formed line scanning densitometry perpendicular to the
margins of cell-cell junctions. The fluorescent inten-
sity of immunostaining for endogenous E-cadherin was
quantified along this axis (Figure 5C), fitted to a Gaussian
curve and scored for the full width at half maximum height
(FWHM) (Figure 5D). Experiments were independently
replicated and as many as 20 individual scans collectively
analyzed to show a statistically significant (p<0.001) in-
crease in peak width due to PP6c knockdown, and this was
rescued to control levels by addition of IC-261 (Figure 5D).
Immunoblotting showed dox induced shRNA-mediated
knock down of endogenous PP6c, without a change in the
levels of PP2A or E-cadherin (Figure 5E). We concluded
that PP6c was required for maintenance of E-cadherin atknockdown and casein kinase 1 inhibition. For inducible knock
irus (B) or subjected to infection with non-coding shRNA virus, as a
observed with confocal microscopy. Cells were treated with or without
PP6c KD cells with or without IC261 treatment. (C) Quantification of
idth at half maximum (FWHM) of each line scan was calculated
] are presented (mean + SE) for each treatment. (E) An immunoblot of
control.
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phosphorylation, probably a site in the cytoplasmic tail of
E-cadherin.
Substitution of Ser846 prevents effects of PP6c
knockdown on E-cadherin localization
Residue Ser846 in murine E-cadherin (human residue
S844) has been established as a substrate for CK1, and
phosphorylation at this site shown to be critical for intern-
alization of E-cadherin off the cell surface [10]. We exam-
ined the localization of epitope-tagged wild type (WT) and
a S846A mutant of murine E-cadherin in Caco-2 cells.
We observed that knockdown of PP6c dispersed WT
E-cadherin from its plasma membrane localization, mim-
icking the effects on endogenous E-cadherin (Figure 6A).
Line scans across cell-cell junctions (Figure 6B) visualized
in the fluorescent microscopic images (Figure 6A) were
fitted to Gaussian curves and analyzed for FWHM
(Figure 6C). Statistical analyses of dozens of scans showed
a significant (p< 0.01) 2-fold increase in FWHM of WT
E-cadherin due to PP6c knockdown (Figure 6C). The
behavior of this tagged version of E-cadherin mimicked the
behavior of the endogenous protein (compare Figures 5A
and 6A). On the other hand, the S846A mutant of
E-cadherin was resistant to effects of PP6c knockdown
(Figure 6C). These data support the conclusion thatFigure 6 Substitution of Ser846 prevents effects of PP6c knockdown
type (WT) or S846A were inserted into the vector with non-coding (Con.) o
infection. Co-expression of myc-E-cadherin and shRNA were induced after
(B) Quantification of fluorescence intensity of myc-E-Cadherin in (A) by line
line scan was calculated and the average of 38 scans [26] are presented (mPP6c-dependent dephosphorylation of this Ser residue
promotes surface localization of E-cadherin in adherens
junctions.
Discussion
E-cadherin is regulated by phosphorylation of its cytoplas-
mic tail and Ser phosphorylation occurs in a region of
densely spaced sites near the C-terminus of the protein
(http://www.phosphosite.org). Phosphorylation of multiple
Ser sites in E-cadherin by CK2 and GSK3 was reported to
enhance association with β-catenin [9]. Multiple Ser to
Ala substitutions to prevent phosphorylation of this region
reduced E-cadherin dependent cell-cell contacts and Ala-
substituted E-cadherin displayed reduced binding to Skp2
that initiates degradation of E-cadherin [11]. On the other
hand, phosphorylation of Ser in E-cadherin by CK1 pro-
moted internalization of E-cadherin [10]. The CK1 site
was mapped to Ser846 (mouse) that lies amongst the CK2
and GSK3 phosphorylation sites. Thus, Ser phosphoryl-
ation of E-cadherin is critical for its stability and intracel-
lular distribution. Although the kinases involved have
been identified, essentially nothing is known about the
protein phosphatases that control the phosphorylation
of these functionally important sites.
Here we provide new evidence for the specific action of
Ser/Thr phosphatase PP6 in the regulation of E-cadherin.on E-cadherin localization. Either myc tagged mouse E-cadherin wild
r PP6c shRNA for stable expression in Caco-2 cells by lentiviral
cell confluence. (A) Immunofluorescent staining of myc-E-cadherin.
scans (10 μm). (C) The full width at half maximum (FWHM) of each
ean + SE).
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epithelial cells and stably associates with E-cadherin-
catenin complexes. We provide evidence for direct
protein-protein interaction between PP6c and the E-
cadherin cytoplasmic tail. Inducible knock down of PP6c
caused internalization of E-cadherin and either chemical
inhibition of CK1 or mutation of a single Ser to Ala
in E-cadherin completely prevented the effects of PP6
knockdown on E-cadherin localization. These results
provide definitive evidence that PP6c opposes CK1
for phosphorylation of the conserved AASLSS sequence
in E-cadherin. We speculate that phosphorylation of this
site supports binding to a protein involved in E-cadherin
internalization. The simplest explanation for our results
is direct dephosphorylation of this Ser in E-cadherin by
PP6, even though we have not demonstrated that reac-
tion with purified proteins. Recombinant PP6c is not
available, and besides phosphatases have historically shown
broad reactivity in vitro with various substrates. It is pos-
sible that E-cadherin becomes dephosphorylated at the
CK1 site by a PP6-dependent mechanism that does not in-
volve direct dephosphorylation.
In high density epithelial cells we observed a striking
accumulation of the PP6c protein. We speculate that
there may be a positive feedback loop from adherens
junctions involving activation of transcription to elevate
PP6 levels to drive dephosphorylation of E-cadherin to
stabilize intercellular junctions. We examined informa-
tion on the PPP6C transcription start site on chromo-
some 9 q33.3 available from ENCODE (http://www.
genome.ucsc.edu). There are ChIP-seq results for over
50 transcription factors and peaks of histone H3 lysine
27 acetylation (H3K27Ac), an epigenetic mark character-
istic of active enhancers, but no obvious connections to
catenin signaling. The nature of any feedback signal to
activate PP6c transcription remains to be discovered.
In animal cells PP6 has been proposed to exist as a
heterotrimeric enzyme comprised of the PP6 catalytic
subunit, one of the three subunits containing a helical-
repeat SAPS domain [13] plus one of three ankyrin re-
peat domain (ANKRD) subunits [19]. In some cell lines
the levels of PP6c and SAPS appear to be co-dependent
in response to knockdown by RNAi, suggesting the pro-
teins do not survive separately, but only as complexes
[20]. Our results indicate PP6c can associate with other
proteins, such as E-cadherin, without participation of
SAPS. We provide evidence for stable association of PP6
with E-cadherin in immunocomplexes and direct protein-
protein binding assay. We do not know what region of the
E-cadherin intracellular domain is involved in binding to
PP6c. There is evidence that PP6c associates with the au-
tophagy protein beclin without involvement of a SAPS sub-
unit (unpublished observation), reinforcing the idea that
PP6c may have other binding partners in cells.Other Ser/Thr phosphatases could also have a role in
the maintenance of adherens junctions. For example it
has been reported that PP2A associates with E-cadherin
in MDCK cells [21], however we did not detect PP2A in
anti-E-cadherin immunoprecipitations (data not shown).
Previous studies found phosphatase PP2A associated
with occludin in tight junctions in Caco-2 cells, not with
adherens junctions [22,23]. This suggests that PP2A and
PP6 are targeted to different junctions within the same cell.
Regardless, our results point to a specific requirement for
PP6c in dephosphorylation of E-cadherin to support cell
surface localization. This implies that changes in the levels
or activity of PP6 due to genetic or environmental factors
would cause phenotypic alterations of epithelial cells.
Conclusions
PP6c associates with E-cadherin-catenin complexes in
adherens junctions without a SAPS subunit and is re-
quired to oppose casein kinase-1 to maintain cell surface
localization of E-cadherin. There is cell density-dependent
feedback signaling to enhance PP6c transcription and
boost mRNA and protein levels.
Methods
Cell culture, antibodies and immunoblotting
Caco-2 cells were grown in DMEM containing 10% FBS,
1x non-essential amino acid (Sigma), 1 mM sodium pyru-
vate (Sigma) and 1x anti-biotic/anti-mycotic (Invitrogen).
ARPE19 cells were obtained from ATCC and were grown
according to ATCC recommendations.
Antibodies were obtained from the indicated suppliers:
rabbit PP6R2, PP6R3 (Bethyl), goat PP2A-A subunit
(Santa Cruz), β-actin (Sigma), rabbit E-cadherin (Cell Sig-
naling), mouse E-cadherin, α-catenin, β-catenin (BD Bio-
science), species specific secondary antibodies IR 680
(Invitrogen), IR800 (LI-COR), Alexa 488 and Alexa 568
(Molecular Probes). Chicken antibodies for PP6c and
PP6R1 and rabbit α-4 antibody were generated as previ-
ously described [13,24]. Mouse anti-PP2Ac monoclonal
antibody was provided by Marc Mumby. Cells were lysed
in a buffer containing 50 mM Tris–HCl (pH 8.0), 1 mM
EDTA, 0.2% SDS, 0.5% Nonidet P-40, 1 mM Na3VO4,
1 μM Microcystin-LR, and Roche Complete protease
inhibitor mixture. The proteins were separated by SDS-
PAGE and transferred onto nitrocellulose membrane
(Bio-Rad). The membranes were blocked with 3% skim
milk and treated with antibodies as described and quanti-
fied by Odyssey infrared scanner and software (Licor Inds.).
Quantitative RT-PCR
Total RNA from Caco-2 cells (0.1 μg) was reverse tran-
scribed in a final incubation volume of 20 μl using a
ThermoScript kit (Invitrogen) at 37°C for 1 h. The re-
sulting first-strand cDNA was subjected to quantitative
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The sequences of primers of PP6c and GAPDH were
adopted from RTPrimerDB primer database (ID: 8029
and 3 respectively). PP6c expression was normalized to an
endogenous GAPDH control. The relative quantitative
value for PP6c compared with GAPDH was expressed as
comparative Ct (2–(ΔCt-Cc)) method.
Luciferase assays of PP6 promoter
The 1500 nt immediately upstream of the PP6 transcription
start site on human chromosome 9 was subcloned into
pGL3basic. Caco2 cells (4 × 106) were co-transfected in
suspension for 3 h using Lipofectamine 2000 (Invitrogen)
with 10:1 ratio of reporter plasmids [pGL3basic hPP6-
report] (12 ug) and phRL-CMV (Promega) (1.2 ug). Follow-
ing transfection, cells were plated in triplicate onto 12 well
dishes at high density (1 × 106 cells/well) and low density
(2 × 105 cells/well). At 72 h following transfection, cells
were lysed with the passive lysis buffer (Promega) and
luciferase activities were measured with a Berthold LB 953
luminometer using a firefly luciferase assay kit (Biotium).
Renilla luciferase activity was measured with 0.09 μM
coelenterazine (Biosynth) in 25 mM Tris, pH 7.5, 100 mM
NaCl in all samples to normalize for transfection efficiency.
Isolation and analysis of membrane and cytosolic fractions
Caco-2 cells were suspended in MOPS buffer (50 mM
MOPS-NaOH (pH 7.4), 125 mM NaCl, 1 mM EGTA,
0.1% 2-mercaptoethanol, and Roche Complete protease
inhibitor) and homogenized by glass pestle homogenizer.
Homogenates were centrifuged (100,000 g) for 20 min
and the supernatant used as the cytosolic fraction. Pel-
lets were resuspended with MOPS buffer and applied on
top of 28% sucrose layered on 50% sucrose. After 40 min
centrifugation (100,000 g), the 28/50% interface was col-
lected and washed with MOPS buffer by centrifugation.
The resulting pellets were solubilized in MOPS buffer
containing 1% Nonidet P-40 and after 15 min centrifuga-
tion (16,000 g), the supernatant was used as the membrane
fraction. Antibodies were bound to protein G-agarose
beads and covalently cross-linked by dimethyl pimeli-
midate treatment (Harlow and Lane [25]). Cytosolic and
membrane fractions of Caco-2 cells were incubated
with antibody-coupled beads. Normal IgG coupled to
beads was used as control.
In vitro PP6 binding assay
Binding assay was performed by incubating S-tag PP6c on
S protein agarose beads with in vitro translated 35S labeled
Flag E-cadherin C-terminal segment. Human PP6c mRNA
sequence was inserted into pTriEX4 vector. pTriEX4 PP6c
or pTriEX4 empty vectors were transfected into HEK293T
cells and cultured for 2 days. Cells were lysed with MOPS
buffer (50 mM MOPS-NaOH (pH 7.4), 125 mM NaCl,1 mM EGTA, 0.1% 2-mercaptoethanol, and Roche Com-
plete protease inhibitor) containing 1% Nonidet P-40.
S-tag PP6c was pulled down by S-protein agarose
(Novagen) at 4°C for 4 h. Precipitates were washed
to remove associated proteins with 2 M Urea/MOPS
buffer twice, with 1 mM ATP/1mM MgCl2/MOPS buffer
once, and then with MOPS buffer once. pGEX5X-1 Rat E-
cadherin cytosolic fragment was provided by Dr. Barry M.
Gumbiner and subcloned into pcDNA3 Flag vector. For
in vitro transcription and translation, TNT T7 coupled Re-
ticulocyte Lysate System (Promega) was used with 35S
methionine. Empty pcDNA3 Flag vector was used as a
control. After 2 h at 4°C beads were washed with MOPS
buffer and binding proteins were separated by SDS-
PAGE and S35 bands visualized with a Phosphor-Imager
(Molecular Dynamics).
Virus production and PP6c knockdown
Short hairpin RNA (shRNA) targeting PP6c (5' CCAG
AACGACAACGCCATATT 3’) was inserted into TRIPZ
vector (Open Biosystems). Lentivirus for expressing of
PP6c shRNA and non-coding shRNA were packaged by
co-transfecting plasmids of lenti-vector, psPAX2 and
VSV-G into HEK293 cells (Addgene). The virus-containing
medium was collected at 48–72 hrs. Adenovirus was pre-
pared using the system developed by He et al. [26]. Briefly,
the fragment containing the shRNA, inducible tetracycline
responsive RNA Polymerase II promoter and turboRFP
was excised and inserted in the shuttle vector, pAdTrack.
The resulting plasmids were cotransfected with the adeno-
viral backbone plasmid, pAdEasy-1, into BJ5183 bacteria.
Recombined plasmid was selected and transfected into
HEK 293 cells to generate virus, which was amplified and
then purified by CsCl gradient ultracentrifugation to create
a high titer viral stock. Viruses encoding the inducible ex-
pression region and turboRFP from TRIPZ vector were
used as a control.
Caco-2 cells were cultured to 80% confluence and
infected with control shRNA or PP6C shRNA virus.
Approximately 6–8 hours post-transduction, media was
replaced containing doxycycline at a concentration of
1 μg/ml. After inducing expression for 4 days, the cells
were treated without or with IC261 (10 μM) for 4 h and
then fixed for fluorescent microscopy.
Co-expression of myc-E-cadherin and shRNA
The AgeI restriction site in the TRIPZ vector containing
the non-coding shRNA and PP6c shRNA was used to li-
gate blunt-ended fragments encoding mouse E-cadherin
wild type (WT) and S846A tagged with myc epitope.
Lentiviruses were produced by transfecting TRIPZ vec-
tor, psPAX2 and pCMV-VSVG in HEK293-LT cells and
virus-containing media were collected at day 2 and 3.
Caco-2 cells were infected with lentivirus and selected
Ohama et al. BMC Cell Biology 2013, 14:42 Page 10 of 11
http://www.biomedcentral.com/1471-2121/14/42with 5 μg/ml puromycin. Cells with stable expression
were induced by doxycycline (1 μg/ml) when they were
confluent. After inducing expression for 4 days cells were
fixed by methanol/acetone (1:1) for immunofluorescence
staining.
Immunofluorescent microscopy
Caco-2 cells were fixed by methanol/acetone (1:1) and
permeabilized with 0.5% Triton X-100 for 20 min. The
specimens were blocked with 10% goat serum for 1 hr at
room temperature. The primary antibodies (E-cadherin
from BD Biosciences 1:200, occludin from BD Biosci-
ences 1:400, ZO-1 from Upstate 1:200, β-catenin from
BD Biosciences 1:200 and c-myc from Santa Cruz 1:200)
were incubated at 4°C for overnight. Secondary anti-
rabbit or anti-mouse antibodies were conjugated with
Alexa fluor-488 or 647 (Invitrogen). The immunofluor-
escent images were captured by Leica SP5 X White
Light confocal microscope. Fluorescence intensity was
measured by line scanning with software in the Leica ap-
plication suite. Results of line scan were plotted with
Gaussian fit and Gaussian full width at half maximum
(FWHM) was calculated.
Statistical analysis
The results are expressed as the means ± S.E. Comparisons
between groups were performed by one-way ANOVA,
followed by Student-Newman-Keuls test. For all of the ana-
lyses, a probability value of p<0.05 was considered as statis-
tically significant.
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